文献速递免疫规划卫生政策与健康促进

种族歧视与健康素养对加拿大种族化社区老年人新冠疫苗有效性认知的影响

Perception of COVID-19 vaccine effectiveness perception in older racialized communities: role of major racial discrimination and health literacy.
PubMed 文献 · Vaccine · 2026-10-05

一项泛加拿大横断面研究于2025年3月通过计算机辅助网络访谈收集数据,纳入581名55岁及以上成年人,分析不同种族背景对新冠疫苗有效性认知的差异。结果显示,65岁及以上人群认知显著高于55-64岁人群;亚裔和白人参与者认知优于黑人和原住民参与者;重大种族歧视经历是疫苗有效性认知较低的最强预测因素,健康素养和黑人身份亦与较低认知相关。

要点

  • 65岁及以上老年人对新冠疫苗有效性的认知显著高于55-64岁人群。
  • 亚裔和白人参与者对疫苗有效性的认知优于黑人和原住民参与者。
  • 重大种族歧视经历是疫苗有效性认知较低的最强预测因素。

核心结论

  • 加拿大55岁及以上人群对新冠疫苗有效性的认知因种族背景而异,差异与歧视经历和健康素养水平相关。
  • 需采取针对性的公平导向公共卫生策略,同时应对结构性种族主义和错误信息,以提升边缘化社区老年人的疫苗信心。

研究设计与样本

  • 横断面泛加拿大研究,采用计算机辅助网络访谈于2025年3月收集数据。
  • 共纳入581名参与者,包括阿拉伯裔(11.5%)、亚裔(15.8%)、黑人(16.2%)、原住民(9%)和白人(35.8%)。
  • 参与者中男性占48.2%,女性占43.0%,8.8%认同为非二元性别。
  • 采用t检验、方差分析和多变量线性回归分析新冠疫苗有效性认知。

主要发现

  • 65岁及以上参与者报告的新冠疫苗有效性认知显著高于55-64岁参与者(t(579)=2.17,p=.015)。
  • 亚裔和白人参与者相比黑人和原住民参与者更可能对新冠疫苗有良好认知(F(6,574)=2.88,p=.009)。
  • 多变量线性回归显示,重大种族歧视是疫苗有效性认知较低的最强预测因素(β=-0.42,p=.006)。
  • 健康素养与疫苗有效性认知较高相关(β=0.09,p=.002)。
  • 相比白人,黑人身份与疫苗有效性认知较低相关(β=-1.49,p=.020)。

临床怎么用

  • 针对种族化社区老年人制定公平导向的公共卫生策略,重点解决结构性种族主义和错误信息问题。
  • 在提升疫苗信心的干预中,应同时考虑歧视经历和健康素养水平的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Vaccination has been scientifically proven to be safe and to prevent infectious diseases. The COVID-19 vaccine has been crucial in combating the pandemic. In Canada, despite widespread vaccine hesitancy, little has specifically addressed older adults from racialized communities. This study investigates perceptions of COVID-19 vaccine effectiveness among older adults by racial background, examining the influence of major racial discrimination and health literacy. STUDY DESIGN: A cross-sectional pan-Canadian study. METHODS: Data were collected using Computer-Assisted Web Interviewing (March 2025). The COVID-19 vaccine effectiveness was tested with t-tests, ANOVA, and multivariable linear regression. RESULTS: 581 participants were included: Arab (11.5%), Asian (15.8%), Black (16.2%), Indigenous (9%), and White (35.8%); including men (48.2%), women (43.0%), and 8.8% identifying as non-binary. Participants 65 years and above reported significantly greater perceived COVID-19 vaccine effectiveness versus 55-64 years old (t(579) = 2.17, p = .015)). Asian and White participants were more likely to have a good perception of COVID-19 vaccines versus Black and Indigenous (F(6,574) = 2.88, p = .009) participants. Multivariable linear regression revealed that major racial discrimination was the strongest predictor of lower perception of vaccine effectiveness (β = -0.42, p = .006), along with literacy (β = 0.09, p = .002) and identifying as Black compared to White (β = -1.49, p = .020). CONCLUSIONS: Perceptions of COVID-19 vaccine effectiveness among 55+ in Canada varied substantially across racial groups, with differences linked to experiences of discrimination and literacy levels. These findings highlight the need for targeted, equity-oriented public health strategies that address both structural racism and misinformation to improve vaccine confidence among older adults in marginalized communities.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Beogo I, Xu Y, Kibret TC, et al. Perception of COVID-19 vaccine effectiveness perception in older racialized communities: role of major racial discrimination and health literacy. Vaccine. 2026. PMID: 42832932. doi:10.1016/j.vaccine.2026.129214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。